SCHEMBL12951969

SCHEMBL12951969

O=C[C@@]12C[C@H]1/C=C\CCCCCNC(=O)[C@@H]1CCC[C@H]1C(=O)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12658467 0.79 CCR2 (0.31) —
SCHEMBL30152453 0.61 CCR2 (0.42) —
SCHEMBL15958833 0.59 CCR2 (0.43) —
SCHEMBL7618478 0.59 CCR2 (0.43) —
SCHEMBL15958834 0.59 CCR2 (0.43) —
SCHEMBL12116735 0.59 CCR2 (0.43) —
SCHEMBL12116414 0.59 CCR2 (0.43) —
SCHEMBL11553248 0.57 L3MBTL1 (0.40) —
SCHEMBL17138841 0.57 L3MBTL1 (0.40) —
SCHEMBL13158339 0.57 CCR2 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912999-B1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS TIBOTEC PHARM LTD (IE) 2011-01-05 — — EP disclosed
Send feedback